HS-104

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameHS-104
Drug Alias NameHS-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsPhosphatidylinositol 3-kinases
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInha University
China Registration ClassN/A

Develop Information

Active CompaniesInha University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A